Reduced incretin effect in Type 2 (non-insulin-dependent) diabetes

By M. Nauck, F. Stöckmann, R. Ebert, W. Creutzfeldt. Diabetologia, 2006

1,290 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Obstetrics and Gynecology

View Paper: https://www.semanticscholar.org/paper/85436176b00e00bbfc294aab51c7d3a8fd7f2712

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. Josephine M. Egan
2. Wook Kim
3. J. Meier
4. M. Nauck
5. J. Gromada
6. Jens J. Holst
7. Ralph DeFronzo
8. D. J. Drucker

In Obstetrics and Gynecology

1. J. Meier
2. M. Nauck

Citations in the corpus

• The Role of Incretins in Glucose Homeostasis and Diabetes Treatment (2008, background): “C. Incretin Secretion in Type 2 Diabetes T2DM is characterized by a severely impaired or absent GIP insulinotropic effect (Nauck et al., 1986) (to be further discussed in section V) that most likely results in worsening insulin secretion.”
• Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. (2004, background): “When investigated using isoglycemic oral and intravenous glucose challenges, such patients have almost no, or a greatly reduced, incretin effect (56).”
• Incretin hormones: Their role in health and disease (2018, methodology): “Reproduced from Nauck et al.(3) with permission (Diabetologia, Springer) 6 NAUCK AND MEIER”
• Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. (2008, background): “(50), resulting in postprandial hyperglycemia, a predictor of cardiovascular complications and mortality (51).”